Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension.
about
Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cellsUnique aspects of the developing lung circulation: structural development and regulation of vasomotor toneActivation of Notch3 promotes pulmonary arterial smooth muscle cells proliferation via Hes1/p27Kip1 signaling pathwayDistinct ETA receptor binding mode of macitentan as determined by site directed mutagenesisRole of Hypoxia-Induced Brain Derived Neurotrophic Factor in Human Pulmonary Artery Smooth MuscleModulating the dysregulated migration of pulmonary arterial hypertensive smooth muscle cells with motif mimicking cell permeable peptidesTransgenic expression of human matrix metalloproteinase-1 attenuates pulmonary arterial hypertension in mice.Versican accumulates in vascular lesions in pulmonary arterial hypertension.Baicalin Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension to Improve Hypoxic Cor Pulmonale by Reducing the Activity of the p38 MAPK Signaling Pathway and MMP-9.BDNF secretion by human pulmonary artery endothelial cells in response to hypoxia.Inhibition of phosphodiesterase-5 suppresses calcineurin/NFAT- mediated TRPC6 expression in pulmonary artery smooth muscle cellsHistone deacetylase inhibitors promote eNOS expression in vascular smooth muscle cells and suppress hypoxia-induced cell growth.Knockdown of AMPKα2 Promotes Pulmonary Arterial Smooth Muscle Cells Proliferation via mTOR/Skp2/p27(Kip1) Signaling Pathway.5-HT induces PPAR γ reduction and proliferation of pulmonary artery smooth muscle cells via modulating GSK-3β/β-catenin pathway.Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p.Unraveling endothelin-1 induced hypercontractility of human pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension.Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH.
P2860
Q21133932-2BDC86F4-8753-41A5-938A-DDCA34A432E0Q28076917-D160894F-B0EF-4CF0-BD9A-632E40F048CEQ28387417-C3781304-A86C-46B9-929D-DFA3D6E22470Q35256194-758B16B3-232A-466A-AF17-0DCFD512C5DBQ35698710-66ECB50D-63B6-4462-A6CB-D9786604AC81Q36955886-6AF3B3B6-D907-4148-9F4A-B7545BD1F65EQ37100777-924F4F0B-6772-4D51-985F-A0802E6806E0Q37248333-484C4516-12E6-428C-9F32-5B694981931BQ37256775-A3BF100F-A2AD-4DC0-BC8D-F99AFE0C3819Q37688363-AC8009EB-5279-4974-A027-A4B5B0102C5DQ41075480-66463BDD-540D-4391-9BAC-6B745F12D5BEQ41520325-0BDA17BC-E7D2-4D08-98DA-BBC53F6DEC59Q41974999-846F3B01-CFE9-4E39-9F4E-EEDED4DECB4EQ42700724-24A51BE6-F74F-4941-B8CB-70336E1312FFQ42941127-7DBA1C23-8D14-4026-A3F6-B2EAB08A7300Q52719802-6FF285BA-0FF6-4F8F-A75D-40B518FBB4B4Q53686493-741432EC-31E5-4917-A087-105D3843A4A3
P2860
Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Smooth muscle cell hypertrophy ...... sis in pulmonary hypertension.
@en
type
label
Smooth muscle cell hypertrophy ...... sis in pulmonary hypertension.
@en
prefLabel
Smooth muscle cell hypertrophy ...... sis in pulmonary hypertension.
@en
P2860
P356
P1476
Smooth muscle cell hypertrophy ...... sis in pulmonary hypertension.
@en
P2093
Nicholas W Morrell
Tamara Tajsic
P2860
P304
P356
10.1002/CPHY.C100026
P577
2011-01-01T00:00:00Z